News

News

PublISHED ON 23 September 2020

UpDATED ON 23 September 2020

10 million SEK to national study of COVID-19

The Swedish Research Council is providing 10 million SEK to fund the ImmCoVA clinical study. The study is expected to run for three years, and focuses on immune blockers to counteract excess reaction of the immune system to the infection caused by COVID-19.

Foto: Chris McLay, Unsplash

In June, we reported that the Swedish Research Council was to fund Sweden’s participation in the Solidarity trial, a major clinical WHO study, where a number of antiviral medicines are tested on patients being treated for COVID-19. However, due to the high level of mortality seen in patients receiving some of these medicines, the Swedish network for the WHO study decided that Sweden would not participate in the study.

Instead, the Swedish Research Council is now providing the same network of infection clinics in Sweden with funding of 10 million SEK to conduct another national study into COVID-19. The study is called ImmCoVA, and is expected to run for three years, starting in October. The study focuses on immune blockers to counteract excess reaction of the immune system to infection, known as ‘cytokine storm’. The study will investigate whether treatment with two specific immunosuppressing substances can result in improvement, and at best in patients recovering more quickly than with standard treatments.

The Karolinska University Hospital is leading the study, and patients will be recruited from five university hospitals.

PUBLISHED ON 23 September 2020

UpDATED ON 23 September 2020

MORE WITHIN THE SAME SUBJECT AREA

  1. Swedish Research Council to fund research into COVID-19 vaccine and long COVID

    The Government has tasked the Swedish Research Council to allocate 150 million SEK to research into COVID-19 vaccine and long COVID. “We are working as fast as we can to issue calls for the funding,” says Madeleine Durbeej-Hjalt, Secretary General fo...

  2. New members of the Committee for Clinical Therapy Research

    The 2021 Committee for Clinical Treatment Research has now been appointed. Eight of the members are new and five are re-elected. The new chairman is Miia Kivipelto.

  3. Interdisciplinary research environments